A Trusted Partner in MedTech Manufacturing manufacturing, especially as the landscape continues to undergo significant evolution. The injectable drug delivery market is changing rapidly. Growth in biologics, GLP-1 therapies, self-administration, drug-device combination products, and patient-centric delivery formats is placing new pressure on manufacturing capacity, device platforms, and industrialisation pathways. Innovation in this environment is not only about inventing and industrialising new devices, but also about helping clients scale safety, validate robustly, transfer effectively, and bring products to market with less friction. Moving forward, Andy and his team strive to ease the industry’s pain points and tackle these challenges head-on. “Our goal is to build Quvara Medical into a trusted manufacturing partner for pharmaceutical, biotechnology, and medtech organisations requiring high-quality device manufacturing support,” he told us. “We want to be recognised for technical discipline, responsive partnership, and the ability to help clients bridge the gap between product ambition and industrial reality.” He continued: “We are also focused on creating a scalable commercial platform: one that can support existing device categories, adjacent injectable and syringe-related opportunities, and future growth areas where manufacturing excellence and regulatory confidence are decisive.” Since its creation in 2025, Andy has led the Quvara Medical team from strength to strength, successfully establishing the company as an invaluable partner to countless clients across the pharmaceutical, biotechnology, and medical technology sectors. The Chief Commercial Officer has demonstrated the importance on aligning strategy, capability, and culture across organisations, showcasing how a team operating with a shared vision can achieve sustained success. For his exceptional leadership capabilities and significant contributions to the medical technology field, Andy Wertheim has been deservingly recognised as the UK’s Most Strategic MedTech Commercial Leader 2026. To aspiring business leaders who hope to follow in these ambitious footsteps, Andy advised: “My advice would be to become fluent in both strategy and delivery but always centred on people. People are the key. Many talk about growth, transformation, or opportunity. Fewer can turn these ideas into practical action, measurable progress, and organisational confidence. The strongest leaders connect the big picture with the operational detail.” Contact: Andy Wertheim Company: Quvara Medical Ltd Web Address: www.quvaramedical.com
RkJQdWJsaXNoZXIy MTUyMDQwMA==